OMass Therapeutics Raises $310 Million in Funding Round
U.K. startup OMass Therapeutics raised $310 million, with Novo Holdings, Bain Capital and Forbion leading the round. Janus Henderson Investors, SV Health Investors and Jefferson Life Sciences also provided funding.
U.K. startup OMass Therapeutics raised $310 million in a funding round that ranks among the biggest European biotech financings this year. Novo Holdings, Bain Capital and Forbion led the round. Janus Henderson Investors, SV Health Investors and Jefferson Life Sciences also participated.